Van Gilst WH - Search Results

1

The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.

Van Veldhuisen DJ, Girbes AR, Crijns HJ, Smit AJ, Van Gilst WH, Lie KI. Van Veldhuisen DJ, et al. Among authors: van gilst wh. Int J Clin Pharmacol Res. 1991;11(3):159-65. Int J Clin Pharmacol Res. 1991. PMID: 1687321

2

Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.

van Wijngaarden J, Monnink SH, Bartels H, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. van Wijngaarden J, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 1992 May;19(5):741-7. J Cardiovasc Pharmacol. 1992. PMID: 1381772

3

Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.

Wiesfeld AC, Crijns HJ, Van Veldhuisen DJ, Van Gilst WH, Lie KI. Wiesfeld AC, et al. Among authors: van gilst wh, van veldhuisen dj. Clin Cardiol. 1992 Sep;15(9):689-92. doi: 10.1002/clc.4960150912. Clin Cardiol. 1992. PMID: 1395204 Free article.

4

Differences in vasomotor control between human gastroepiploic and left internal mammary artery.

Buikema H, Grandjean JG, van den Broek S, van Gilst WH, Lie KI, Wesseling H. Buikema H, et al. Among authors: van gilst wh, van den broek s. Circulation. 1992 Nov;86(5 Suppl):II205-9. Circulation. 1992. PMID: 1424001

5

Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.

van Wijk LM, Crijns HJ, Kingma HJ, van Gilst WH, van Gelder IC, Wesseling H, Lie KI. van Wijk LM, et al. Among authors: van gilst wh, van gelder ic. J Cardiovasc Pharmacol. 1990 Jun;15(6):884-91. J Cardiovasc Pharmacol. 1990. PMID: 1694910

6

The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.

van den Broek SA, van Bruggen A, de Graeff PA, Hillege H, van Gilst WH, Wesseling H, Lie KI. van den Broek SA, et al. Among authors: van gilst wh, van bruggen a. J Cardiovasc Pharmacol. 1991 Oct;18(4):614-21. doi: 10.1097/00005344-199110000-00019. J Cardiovasc Pharmacol. 1991. PMID: 1724540

7

[The use of positron emission tomography in cardiology; a metabolic dimension].

Blanksma PK, Vaalburg W, Paans AM, Meeder J, van Gilst WH, Lie KI. Blanksma PK, et al. Among authors: van gilst wh. Ned Tijdschr Geneeskd. 1991 Jan 5;135(1):9-13. Ned Tijdschr Geneeskd. 1991. PMID: 1846674 Review. Dutch. No abstract available.

8

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Crijns HJ, et al. Among authors: van gilst wh, van gelder ic. Am J Cardiol. 1991 Aug 1;68(4):335-41. doi: 10.1016/0002-9149(91)90828-9. Am J Cardiol. 1991. PMID: 1907089

9

Xamoterol in autonomic and intrinsic sinus node dysfunction.

van den Berg MP, Viersma JW, van Gilst WH, Lie KI. van den Berg MP, et al. Among authors: van gilst wh. Am J Cardiol. 1990 Mar 15;65(11):814-6. doi: 10.1016/0002-9149(90)91397-o. Am J Cardiol. 1990. PMID: 1969224 Clinical Trial. No abstract available.

10

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.

Van Gelder IC, Crijns HJ, Van der Laarse A, Van Gilst WH, Lie KI. Van Gelder IC, et al. Among authors: van gilst wh, van der laarse a. Am Heart J. 1991 Jan;121(1 Pt 1):51-6. doi: 10.1016/0002-8703(91)90954-g. Am Heart J. 1991. PMID: 1985377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters